PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission
TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) — via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on…
Pharmaceuticals, Biotechnology and Life Sciences
TARRYTOWN, New York, April 11, 2024 (GLOBE NEWSWIRE) — via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on…
PITTSBURGH, April 11, 2024 (GLOBE NEWSWIRE) — Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health…
CAMBRIDGE, Mass., April 11, 2024 (GLOBE NEWSWIRE) — Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the…
SAN DIEGO, April 11, 2024 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on April 10, 2024,…
LEXINGTON, Mass., April 11, 2024 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing…
SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein…
For Americans who enjoy cannabis and roll their eyes at U.S. politics, Capitol 9 proudly presents politically themed THC seltzers…
Nes-Ziona, Israel, April 11, 2024 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy…
Oxurion Receives Transparency Notifications from Atlas Special Opportunities LLC Leuven, BELGIUM – April 11, 2024 – 07:00 PM CET Oxurion…
OCALA, Fla., April 11, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), today announced the…